Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00799994 · ClinicalTrials.gov registry record
Does Lowering Eye Pressure Affect the Results Obtained From Objective Visual Field Testing?
A clinical trial, sponsored by Wills Eye.
- Completed
- Registry status
- 23
- Enrollment target
NCT00799994 is a clinical trial that has completed, run by Wills Eye. The registered enrollment target is 23 participants.
The verdict
NCT00799994 has completed, sponsored by Wills Eye.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
A study to determine whether a patient's range of vision test results improve after their eye pressure is lowered by 30% or more by testing on a new machine called the Accumap and how to learn how much the Accumap's results change from one test to another within the same person. The investigators believe that Multifocal VEP readings (Accumap)(and therefore visual function and ganglion cell function) improve after acutely lowering intraocular pressure.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2004-10 |
| Est. Completion | 2007-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00799994
The ClinicalTrials.gov registry entry for NCT00799994 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wills Eye, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00799994 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00799994 about?
NCT00799994 is a clinical study titled "Does Lowering Eye Pressure Affect the Results Obtained From Objective Visual Field Testing?". A study to determine whether a patient's range of vision test results improve after their eye pressure is lowered by 30% or more by testing on a new machine called the Accumap and how to learn how much the Accumap's results change from one test to another within the same person. The investigators b...
What is the current status of trial NCT00799994?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2004-10. Estimated completion is 2007-01.
Who is sponsoring clinical trial NCT00799994?
This trial is sponsored by Wills Eye, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.